Table 3 Uni- and multivariate Cox regression analysis of overall survival prognosis in CGGA dataset.
From: RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% Cl) | P-value | HR (95% Cl) | P-value | |
WHO grade | ||||
 G2 | Reference |  |  |  |
 G3 | 3.576 (2.338–5.471) |  < 0.001 | 3.399 (2.204–5.242) |  < 0.001 |
 G4 | 8.74 (5.881–12.988) |  < 0.001 | 5.916 (3.842–9.110) |  < 0.001 |
Gender | 0.934 (0.708–1.232) | 0.631 |  |  |
Age | 1.032 (1.020–1.046) |  < 0.001 | 1.014 (1.002–1.026) | 0.027 |
IDH | 0.355 (0.268–0.471) |  < 0.001 | 1.213 (0.861–1.708) | 0.27 |
1p19q | 0.170 (0.104–0.277) |  < 0.001 | 0.268 (0.158–0.454) |  < 0.001 |
MGMT | 0.868 (0.659–1.144) | 0.315 |  |  |
RBM47 expression | 1.122 (1.088–1.157) |  < 0.001 | 1.047 (1.010–1.086) | 0.013 |
